等待开盘 10-16 09:30:00 美东时间
+0.520
+2.27%
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by v...
10-14 19:27
今日重点评级关注:Truist Securities:维持Inventiva"买入"评级,目标价从13美元升至18美元;富瑞:维持Sagimet Biosciences"买入"评级,目标价从25美元升至26美元
10-05 16:26
Citizens analyst Mitch Germain maintains VICI Properties (NYSE:VICI) with a Market Outperform and lowers the price target from $35 to $31.
10-02 20:55
VICI Properties (VICI) announced on Monday that it will enter a new 20-year triple-net lease with Highfield for the real estate at Century Mile and Century Downs racetracks in Alberta, Canada. The lea...
09-28 21:46
Las Vegas is on the tail end of a rare citywide five-day sale that ran this week. The Vegas 5-Day sale sees resorts cut prices on rooms, dining, entertainment, and attractions as the industry looks to...
09-26 01:27
今日重点评级关注:Canaccord Genuity:维持Aurora Innovation"买入"评级,目标价从15美元升至17美元;摩根大通:维持皇家加勒比邮轮"超配"评级,目标价从345美元升至394美元
09-25 15:55
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Piper Sandler analyst Peter Keith downgraded Rollins Inc (NYSE:ROL) from Overweight to Neutral an...
09-24 22:16
Scotiabank analyst Nicholas Yulico maintains VICI Properties (NYSE:VICI) with a Sector Perform and lowers the price target from $29 to $26.
09-24 20:46
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25